Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
Hepatobiliary Surgery and Nutrition · 2023-04 · 12 (2) · 169-182
DOI: 10.21037/hbsn-21-196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatobiliary Surgery and Nutrition, 2023-04. Verfasst von Ming Chao Tsai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Med…. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Barcelona clinic liver cancer (BCLC) stage B (intermediate stage) hepatocellular carcinoma (HCC) is highly heterogeneous; thus, identifying the most effective treatment for individual patients represents a significant clinical challenge. However, transarterial chemoembolization (TACE) is the only recommended treatment option. Therefore, we aimed to investigate the patient characteristics and outcomes of living donor liver transplantation (LDLT) for BCLC stage B HCC.
Methods
A total of 516 patients with BCLC stage B HCC who underwent LDLT (n=104) or did not undergo LDLT (non-LDLT; n=412) between 2004 to 2018 were analyzed by propensity score matching (PSM; 1:4) analysis. Factors influencing overall survival (OS) and recurrence were analyzed using Cox's proportional hazards models.
Results
Patients treated with LDLT achieved better OS than the non-LDLT group, including liver- and non-liver related survival (all P 60 years (P=0.006), a neutrophil-lymphocyte ratio (NLR) >4 (P=0.016) and >3 locoregional therapies (LRT) before LDLT (P 60 years (P 3 LRT before LDLT (P=0.001) were independent risk factors for OS. Using a combination of age, NLR, and LRT before liver transplantation (LT), the patients can be divided into low-risk (none of risk), intermediate-risk (one of risk), and high risk (more than two of risk) groups. There were significant differences in the cumulative HCC recurrence (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepato-Gastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung.
- School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung.
- Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung.
- Division of Liver and Transplantation Surgery, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan.
- Liver Transplantation Center and Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung.
- Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung.
Zitieren
APA
Tsai, M. C., Yong, C. C., Lin, C. C., Lee, W. C., Wang, C. C., Hung, C. H., Chen, I. H., Cheng, Y. F., Hsiao, C. C., Hu, T. H., & Chen, C. L. (2023). Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma. Hepatobiliary Surgery and Nutrition, 12(2), 169-182. https://doi.org/10.21037/hbsn-21-196
Vancouver
Tsai MC, Yong CC, Lin CC, Lee WC, Wang CC, Hung CH, et al. Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma. Hepatobiliary Surgery and Nutrition. 2023;12(2):169-182. doi:10.21037/hbsn-21-196
BibTeX
@article{Tsai2023,
author = {Tsai, Ming Chao and Yong, Chee-Chien and Lin, Chih-Che and Lee, Wei-Chen and Wang, Chih-Chi and Hung, Chao-Hung and Chen, I-Hsuan and Cheng, Yu-Fan and Hsiao, Chang-Chun and Hu, Tsung-Hui and Chen, Chao-Long},
title = {Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma},
journal = {Hepatobiliary Surgery and Nutrition},
year = {2023},
volume = {12},
number = {2},
pages = {169--182},
doi = {10.21037/hbsn-21-196}
}
EUVIMED